<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04768634</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-P00037574</org_study_id>
    <nct_id>NCT04768634</nct_id>
  </id_info>
  <brief_title>Predicting Arrhythmogenic Risk in Congenital Heart Patients: the PRECISION Study</brief_title>
  <official_title>Predicting Arrhythmogenic Risk in Congenital Heart Patients: the PRECISION Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Heart Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Children's Heart Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Children's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this research study we want to learn more about abnormal heart rhythm after cardiac&#xD;
      surgery in children. These abnormal heart rhythms, also called arrhythmias, may occur due to&#xD;
      several reasons after cardiac surgery. They can be due to abnormal electrical pathway or an&#xD;
      irritable area of the heart that stimulates abnormal impulses. Regardless of the cause,&#xD;
      arrhythmias after cardiac surgery can be a problem, extending the hospital stay, requiring&#xD;
      additional medications and even leading to cardiac arrest.&#xD;
&#xD;
      Current practice is to monitor for arrhythmias after cardiac surgery, and to treat them if&#xD;
      they occur. With this research, we want to investigate whether we can identify patients who&#xD;
      will develop arrhythmia, and treat them before they occur.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized controlled trial of provocative electrophysiology testing&#xD;
      and prophylactic treatment of inducible SVT versus expectant management&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 23, 2021</start_date>
  <completion_date type="Anticipated">March 2024</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with supraventricular tachycardia</measure>
    <time_frame>Through hospital discharge after cardiac surgery, or up to 90 days</time_frame>
    <description>Number of days post-operatively at time of supraventricular tachycardia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with adverse events related to provocative electrophysiology testing</measure>
    <time_frame>Through hospital discharge after cardiac surgery, or up to 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with sustained supraventricular tachycardia</measure>
    <time_frame>Through hospital discharge after cardiac surgery, or up to 90 days</time_frame>
    <description>Number of days post-operatively at time of sustained supraventricular tachycardia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with other tachyarrhythmias</measure>
    <time_frame>Through hospital discharge after cardiac surgery, or up to 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days post-operatively at time of extubation</measure>
    <time_frame>Through hospital discharge after cardiac surgery, or up to 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days post-operatively in the intensive care unit</measure>
    <time_frame>Though hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days in the hospital</measure>
    <time_frame>Through hospital discharge after cardiac surgery, or up to 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with adverse events related to antiarrhythmic treatment</measure>
    <time_frame>Through hospital discharge after cardiac surgery, or up to 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with major adverse cardiac events (including need for CPR, ECMO or death)</measure>
    <time_frame>Through hospital discharge after cardiac surgery, or up to 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with supraventricular tachycardia after hospital discharge</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Arrhythmia in Children</condition>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>Observation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will be observed for arrhythmias and treated if they occur.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Testing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo provocative electrophysiology testing, and antiarrhythmic medication considered if arrhythmias can be induced.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Provocative electrophysiology study</intervention_name>
    <description>Provocative electrophysiology testing will be performed at the bedside using the temporary pacing wires placed at the time of surgery.</description>
    <arm_group_label>Testing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged &lt; 18 years of age on admission to the cardiac intensive care unit&#xD;
             following cardiac surgery with a predicted probability of supraventricular tachycardia&#xD;
             &gt;10%&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients following orthotopic heart transplant, ventricular assist device&#xD;
             implantation, primary extracorporeal membrane oxygenation cannulation, pacemaker or&#xD;
             implantable cardioverter-defibrillator implantation or sympathectomy&#xD;
&#xD;
          -  Patients on antiarrhythmic medication at the time of surgery&#xD;
&#xD;
          -  Patients with atrioventricular conduction disease (1st degree atrioventricular block&#xD;
             with PR interval greater than 200 ms, 2nd degree atrioventricular block or complete&#xD;
             heart block)&#xD;
&#xD;
          -  Patients with severe ventricular dysfunction in whom therapy with beta-blocker or&#xD;
             sotalol is deemed contra-indicated by the primary team&#xD;
&#xD;
          -  Patients with absent or non-functioning atrial pacing wires&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Audrey Dionne, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Audrey Dionne, MD</last_name>
    <phone>6173552079</phone>
    <phone_ext>45094</phone_ext>
    <email>audrey.dionne@cardio.chboston.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Audrey Dionne, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>February 8, 2021</study_first_submitted>
  <study_first_submitted_qc>February 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2021</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children's Hospital</investigator_affiliation>
    <investigator_full_name>Audrey Dionne</investigator_full_name>
    <investigator_title>Pediatric Cardiologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

